Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.

@article{Kleppe2018DualTO,
  title={Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.},
  author={M. Kleppe and R. Koche and L. Zou and P. van Galen and Corinne E. Hill and L. Dong and Sofie De Groote and Efthymia Papalexi and A. V. Hanasoge Somasundara and K. Cordner and M. Keller and N. Farnoud and Juan S Medina and Erin McGovern and Jaime M. Reyes and Justin D. Roberts and M. Witkin and Franck Rapaport and J. Teruya-Feldstein and Jun Qi and R. Rampal and B. Bernstein and J. Bradner and R. Levine},
  journal={Cancer cell},
  year={2018},
  volume={33 4},
  pages={
          785-787
        }
}
Yong Yu, Kolja Schleich, Bin Yue, Sujuan Ji, Philipp Lohneis, Kristel Kemper, Mark R. Silvis, Nouar Qutob, Ellen van Rooijen, Melanie Werner-Klein, Lianjie Li, Dhriti Dhawan, Svenja Meierjohann, Maurice Reimann, Abdel Elkahloun, Steffi Treitschke, Bernd Dörken, Christian Speck, Frédérick A. Mallette, Leonard I. Zon, Sheri L. Holmen, Daniel S. Peeper, Yardena Samuels, Clemens A. Schmitt,* and Soyoung Lee *Correspondence: clemens.schmitt@charite.de https://doi.org/10.1016/j.ccell.2018.03.009 
62 Citations
Murine Models of Myelofibrosis
...
1
2
3
4
5
...